VIDEO: Surface Pharmaceuticals thrives in OCTANe environment

NEWPORT BEACH, Calif. — At OCTANe’s Ophthalmology Technology Summit, Kamran Hosseini, CEO of Surface Pharmaceuticals, discusses how the company has been working with OCTANe and the Visionary Venture Fund in developing its products for anterior segment surgery.

Full Story →